MD 12 - High-risk steatotic liver disease: new developments in non-invasive tests and treatment - recommendations for clinical practice and directions for the future
March 6, 08:00 - 09:00 CET
2 min
Chairperson's introduction
Valérie Vilgrain, Clichy / France
To highlight new developments in the diagnosis and treatment of high-risk steatotic liver disease.
To critically review recent evidence in imaging and put this in perspective with the new treatment developments.
To provide recommendations for clinical practice and directions for the future.